An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts
An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts
复制标题
DOI:
10.1210/clinem/dgaa347
复制
发表时间:
2020-09-01
影响因子:
5.8
通讯作者:
Mitchell, Anna Louise
中科院分区:
文献类型:
--
作者:
Lane, Laura Claire;Kus, Aleksander;Mitchell, Anna Louise
Context: The genetic background of young-onset Graves disease (GD) remains largely unknown. An intronic variant in human leukocyte antigen (HLA) complex P5 (HCP5) has previously been associated with GD susceptibility and age of onset in a cohort of Polish patients.Objective: We aimed to investigate the association of the HCP5 variant rs3094228 with GD susceptibility and age of onset in a UK cohort and conduct a meta-analysis of UK and Polish data.Design and Participants: rs3094228 was genotyped in 469 UK patients with GD using Taqman chemistry. Genotype frequencies were compared with genotypic data available from the Wellcome Trust casecontrol consortium using logistic regression analysis. To determine whether rs3094228 is independently associated with age of GD onset, the HLA DRB1*0301 tagging variant, rs535777, was also genotyped.Results: The C allele of rs3094228 was overrepresented in the UK GD cohort compared with controls (P-allele=5.08 x 10(-9), odds ratio 1.76; [95% confidence interval, 1.46-2.13]). This association was more marked in young-onset GD (